Case reports of relatively young COVID-19 patients who developed Parkinson's disease within weeks of contracting the virus have led scientists to wonder if there could be a link between the two conditions. Now, researchers ...
Dec 14, 2021
0
1992
Our body is tuned to function in a synchronous manner with a "circadian" or day-and-night rhythm. Alterations to daily lifestyles due to the current stressful routines people follow can disrupt the body's day-night cycle ...
Aug 19, 2021
0
497
Alzheimer's disease (AD) is a form of progressive dementia interfering with daily living. It is caused by the decline in the number of brain cells resulting in the deterioration of our mental abilities. One of the main reasons ...
Apr 19, 2021
0
4
A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury—preventing further damage. This promising result, found in ...
Mar 19, 2021
0
95
Alzheimer's disease is characterized by the presence of amyloid plaques in the patient's brain. These plaques sequester copper, and contain approximately five times as much as a healthy brain.
Dec 17, 2020
0
9
Problems with the sense of smell appear to be an early indicator of cognitive decline in people with type 2 diabetes. However, it's unknown whether factors such as diet and obesity play a role in who develops these symptoms. ...
Nov 4, 2020
0
20
A new study reveals that the common asthma drug salbutamol may offer potential as a treatment for Alzheimer's disease.
Jul 1, 2020
0
14
Sometimes proteins misfold. When that happens in the human brain, the pileup of misfolded proteins can lead to neurodegenerative diseases like Alzheimer's, Parkinson's and ALS.
May 12, 2020
0
125
Doctors have reported that partial or total loss of the sense of smell is often an early symptom of infection with SARS-CoV-2, the virus that causes COVID-19. Now, researchers reporting in ACS Chemical Neuroscience have shown ...
May 11, 2020
0
46
When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of ...
May 7, 2020
0
233
